Menu
Not yet recruiting NCT07752420

Effects of Structural Integration on Chest Wall Expansion Among COPD Patients

No phase Interventional COPD (With - Without Rehabilitation)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Structural Integration with Conventional Pulmonary Rehabilitation, Pulmonary Rehabilitation only.
Who it may be relevant to
Registry conditions: COPD (With - Without Rehabilitation). Basic parameters: 50 years — 70 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Pakistan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Effects of "The 10-Series of Structural Integration" on Chest Wall Expansion Among COPD Patients

Overview

The present study aims to investigate the effects of the 10-Series of Structural Integration on chest wall expansion in patients with stable COPD using a randomized controlled trial design. Participants receiving Structural Integration in addition to conventional pulmonary rehabilitation will be compared with those receiving conventional pulmonary rehabilitation alone. Chest wall expansion will serve as the primary outcome, while pulmonary function, dyspnea, functional exercise capacity, and quality of life may be evaluated as secondary outcomes.

Interventions

  • Other Structural Integration with Conventional Pulmonary Rehabilitation
    * Conventional pulmonary rehabilitation. * The complete 10-Series of Structural Integration, delivered by a certified Structural Integration practitioner/physiotherapist.
  • Other Pulmonary Rehabilitation only
    Participants receive only the conventional pulmonary rehabilitation program.

Primary outcome measures

  • Chest Wall Expansion [Time frame: Before the start and end of 10 weeks]

Eligibility criteria

Inclusion criteria

  • Clinically diagnosed stable COPD according to GOLD criteria
  • GOLD stage II or III
  • No acute exacerbation within the previous four weeks
  • Able to ambulate independently
  • Medically cleared to participate in pulmonary rehabilitation
  • Willing to provide written informed consent

Exclusion criteria

  • Severe cardiovascular disease contraindicating exercise
  • Recent thoracic or abdominal surgery (<6 months)
  • Rib fractures or severe chest wall deformity
  • Neurological disorders affecting mobility
  • Active malignancy
  • Severe osteoporosis with high fracture risk
  • Previous Structural Integration treatment within the last year

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Supportive care

Study locations

Pakistan · 1 center
  • Ali Fatima Hospital — Lahore

Identifiers

NCT: NCT07752420 · GIU/IRB/110047-1

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗